Chapter 19 presents a non-exhaustive list of 111 substances administered in treatment of pediatric cardiac intensive care patients. Relevant pharmacokinetic and pharmacodynamic details are given for the categories drug name, active compound, efficacy, adverse drug reactions (ADR), indications, contraindications, and recommended dosage. Additional tables provide more specifics on the subjects of beta-blockers, nausea, and phenprocoumon. This very comprehensive tabular compendium is a fitting completion of this practical handbook.
The drug list does not claim to be exhaustive. Many of the products are not licensed for pediatrics or the cited indication (off-label). Irrespective of potential differences in pharmacokinetics and pharmacodynamics, many recommendations are oriented on the adult dosages.